12 to 24 Months Prior to Launch Manufacturers preparing to launch a new product in today’s complex and ever-changing healthcare market often realize they need a strategic partner whose insights can guide today’s critical decisions—the decisions that will impact product uptake at launch. Xcenda has an in-depth understanding of all stakeholders, the experience to anticipate what challenges may lay ahead, and the insight to develop the appropriate strategies to overcome them. Maximize commercial opportunities with the following key services: Conduct a value diagnosticPayers expect health outcomes evidence to support a compelling value proposition that clearly articulates how your product addresses an unmet need. Leverage the findings of a market value framework to position your therapy so payers clearly understand why patients need access.Read MoreAnalyze health policyConsistently monitor the legislative and policy environment to anticipate how current changes could impact the market landscape for your product at launch.Read MoreAnalyze payer mix/payer segmentationWork with us to develop an effective payer segmentation to guide strategies for optimizing product coverage and access.Read MoreSelect a Payer AgencyYou're starting to prepare payers for your product launch. But is your agency prepared? Do they understand the reimbursement landscape your product will face? Do they know how government and private payers perceive your clinical evidence? Select the right partner and gain a strategic advantage leading up to your product launch.Read More 12 to 24 Months Prior to Launch: Additional ServicesExpand AllCollapse AllGather Stakeholder insights with Xcenda's Advisor NetworksMoreStakeholder insights: GMAN, Managed Care Network, Global Provider Insights Network Gather payer, provider, and patient insights to prepare for launch. Test clinical messages, train account managers with mock P&T meetings, and identify leading indicators of practice behavior.Global Value DossiersMoreGlobal Value Dossiers It's more than a requirement. It's an invaluable tool to showcase your product value evidence and command market access around the world.Economic modelsMoreEconomic models Whether required for regulatory submission or a necessary component of an effective account manager toolkit, manufacturers use models to demonstrate budget impact, cost-effectiveness, or disease burden.Scientific publicationsMoreScientific publications Begin planning your publication strategy now so payers recognize your product at launch. Our experienced medical writers will effectively message your product's clinical evidence to payers through peer-reviewed publications and scientific posters.CompendiaMoreCompendia Monitor compendia for new, updated, and changed listings. Evaluate listings for your products and others within relevant disease states. Compare the compendia listings to what payers are covering, and set a sound strategy going forward.CodingMoreCoding Turn to our Certified Professional Coders to navigate the complex world of coding and implement strategies to maximize appropriate access.Patient and Provider Access StrategyMorePatient And Provider Access Strategy (PPAS) Support product uptake at launch with the optimal mix of patient and provider support services. Conduct exposure analyses to estimate the size of potential programs. And uncover the program features and benefits that matter most by conducting a benchmarking analysis. Risk management strategyMoreRisk management strategy Be proactive and approach regulatory decision makers with your recommendations. From routine pharmacovigilance to enhanced risk communication techniques, post-approval safety studies, and performance-linked product access, Xcenda can design a strategy best suited for your product.Contract HEOR staffMoreContract HEOR staff Give payer field teams the HEOR tools required to maximize product reimbursement, in order to support uptake at launch. Supplement your team of HEOR experts with ours, who are available via flexible contract staffing.